These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29917273)

  • 1. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2018 Jan; 37(1):67-82. PubMed ID: 28618110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Schneider MP; Tornic J; Sýkora R; Abo Youssef N; Mordasini L; Krhut J; Chartier-Kastler E; Davies M; Gajewski J; Schurch B; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2019 Aug; 38(6):1482-1491. PubMed ID: 31099113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.
    Abo Youssef N; Schneider MP; Mordasini L; Ineichen BV; Bachmann LM; Chartier-Kastler E; Panicker JN; Kessler TM
    BJU Int; 2017 Apr; 119(4):515-521. PubMed ID: 28058780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
    Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
    Neurourol Urodyn; 2019 Feb; 38(2):563-571. PubMed ID: 30653737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
    Gross T; Schneider MP; Bachmann LM; Blok BF; Groen J; Hoen LA; Castro-Diaz D; Padilla Fernández B; Del Popolo G; Musco S; Hamid R; Ecclestone H; Karsenty G; Phé V; Pannek J; Kessler TM
    Eur Urol; 2016 Jun; 69(6):1102-11. PubMed ID: 26831506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of the neuro-urological patient: a systematic review.
    Averbeck MA; Madersbacher H
    BJU Int; 2015 Apr; 115 Suppl 6():39-46. PubMed ID: 25891319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
    Schneider MP; Gross T; Bachmann LM; Blok BF; Castro-Diaz D; Del Popolo G; Groen J; Hamid R; Karsenty G; Pannek J; Hoen L'; Kessler TM
    Eur Urol; 2015 Nov; 68(5):859-67. PubMed ID: 26194043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review.
    Musco S; Padilla-Fernández B; Del Popolo G; Bonifazi M; Blok BFM; Groen J; 't Hoen L; Pannek J; Bonzon J; Kessler TM; Schneider MP; Gross T; Karsenty G; Phé V; Hamid R; Ecclestone H; Castro-Diaz D
    Neurourol Urodyn; 2018 Jun; 37(5):1522-1540. PubMed ID: 29392753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
    De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
    Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
    Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuro-urological diagnostics and treatment of non-traumatic/degenerative neurogenic lower urinary tract dysfunction exemplified by multiple sclerosis].
    Kurze I; Jaekel AK
    Aktuelle Urol; 2024 Aug; 55(4):315-325. PubMed ID: 38653466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
    Castel-Lacanal E; Gamé X; De Boissezon X; Guillotreau J; Braley-Berthoumieux E; Terracol C; Gasq D; Labrunee M; Viala F; Rischmann P; Clanet M; Marque P
    World J Urol; 2013 Dec; 31(6):1445-50. PubMed ID: 23292297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up.
    Ginsberg DA; Boone TB; Cameron AP; Gousse A; Kaufman MR; Keays E; Kennelly MJ; Lemack GE; Rovner ES; Souter LH; Yang CC; Kraus SR
    J Urol; 2021 Nov; 206(5):1106-1113. PubMed ID: 34495688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation effects on lower urinary tract function: Systematic review and meta-analysis.
    Jörg E; Sartori AM; Hofer AS; Baumann CR; Kessler TM
    Parkinsonism Relat Disord; 2020 Oct; 79():65-72. PubMed ID: 32889502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic Lower Urinary Tract Dysfunction in Adults with Cerebral Palsy: Outcomes following a Conservative Management Approach.
    Goldfarb RA; Pisansky A; Fleck J; Hoversten P; Cotter KJ; Katorski J; Liberman D; Elliott SP
    J Urol; 2016 Apr; 195(4 Pt 1):1009-13. PubMed ID: 26498055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.
    Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A
    Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.
    Sakakibara R
    Clin Auton Res; 2019 Jun; 29(3):313-320. PubMed ID: 30076494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.